Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antiemetic drugs, such as aprepitant, may help lessen or prevent nausea and
vomiting in patients undergoing chemotherapy.
PURPOSE: This randomized clinical trial is studying aprepitant to see how well it works
compared to placebo in preventing nausea and vomiting in patients undergoing chemotherapy for
breast cancer.